These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 21999410)

  • 1. Novel antibody capture assay for paraffin-embedded tissue detects wide-ranging amyloid beta and paired helical filament-tau accumulation in cognitively normal older adults.
    Postupna N; Rose SE; Bird TD; Gonzalez-Cuyar LF; Sonnen JA; Larson EB; Keene CD; Montine TJ
    Brain Pathol; 2012 Jul; 22(4):472-84. PubMed ID: 21999410
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An extensive network of PHF tau-rich dystrophic neurites permeates neocortex and nearly all neuritic and diffuse amyloid plaques in Alzheimer disease.
    Schmidt ML; DiDario AG; Lee VM; Trojanowski JQ
    FEBS Lett; 1994 May; 344(1):69-73. PubMed ID: 8181568
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunotherapy to improve cognition and reduce pathological species in an Alzheimer's disease mouse model.
    Herline K; Prelli F; Mehta P; MacMurray C; Goñi F; Wisniewski T
    Alzheimers Res Ther; 2018 Jun; 10(1):54. PubMed ID: 29914551
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synaptic Amyloid-β Oligomers Precede p-Tau and Differentiate High Pathology Control Cases.
    Bilousova T; Miller CA; Poon WW; Vinters HV; Corrada M; Kawas C; Hayden EY; Teplow DB; Glabe C; Albay R; Cole GM; Teng E; Gylys KH
    Am J Pathol; 2016 Jan; 186(1):185-98. PubMed ID: 26718979
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Is Olfactory Epithelium Biopsy Useful for Confirming Alzheimer's Disease?
    Godoy MDCL; Fornazieri MA; Doty RL; Pinna FR; Farfel JM; Santos GBD; Molina M; Ferretti-Rebustini REL; Leite REP; Suemoto CK; Grinberg LT; Pasqualucci CAG; Voegels RL; Nitrini R; Jacob Filho W
    Ann Otol Rhinol Laryngol; 2019 Mar; 128(3):184-192. PubMed ID: 30501500
    [TBL] [Abstract][Full Text] [Related]  

  • 6. β-amyloid and tau pathology in the aging feline brain.
    Fiock KL; Smith JD; Crary JF; Hefti MM
    J Comp Neurol; 2020 Jan; 528(1):108-113. PubMed ID: 31273784
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Luminex-based quantification of Alzheimer's disease neuropathologic change in formalin-fixed post-mortem human brain tissue.
    Keene CD; Wilson AM; Kilgore MD; Bruner LT; Postupna NO; Darvas M
    Lab Invest; 2019 Jul; 99(7):1056-1067. PubMed ID: 30573871
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alzheimer's disease and non-demented high pathology control nonagenarians: comparing and contrasting the biochemistry of cognitively successful aging.
    Maarouf CL; Daugs ID; Kokjohn TA; Walker DG; Hunter JM; Kruchowsky JC; Woltjer R; Kaye J; Castaño EM; Sabbagh MN; Beach TG; Roher AE
    PLoS One; 2011; 6(11):e27291. PubMed ID: 22087282
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A specific enzyme-linked immunosorbent assay for measuring beta-amyloid protein oligomers in human plasma and brain tissue of patients with Alzheimer disease.
    Xia W; Yang T; Shankar G; Smith IM; Shen Y; Walsh DM; Selkoe DJ
    Arch Neurol; 2009 Feb; 66(2):190-9. PubMed ID: 19204155
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plaque biogenesis in brain aging and Alzheimer's disease. I. Progressive changes in phosphorylation states of paired helical filaments and neurofilaments.
    Su JH; Cummings BJ; Cotman CW
    Brain Res; 1996 Nov; 739(1-2):79-87. PubMed ID: 8955927
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The accumulation rate of tau aggregates is higher in females and younger amyloid-positive subjects.
    Smith R; Strandberg O; Mattsson-Carlgren N; Leuzy A; Palmqvist S; Pontecorvo MJ; Devous MD; Ossenkoppele R; Hansson O
    Brain; 2020 Dec; 143(12):3805-3815. PubMed ID: 33439987
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Post-mortem correlates of in vivo PiB-PET amyloid imaging in a typical case of Alzheimer's disease.
    Ikonomovic MD; Klunk WE; Abrahamson EE; Mathis CA; Price JC; Tsopelas ND; Lopresti BJ; Ziolko S; Bi W; Paljug WR; Debnath ML; Hope CE; Isanski BA; Hamilton RL; DeKosky ST
    Brain; 2008 Jun; 131(Pt 6):1630-45. PubMed ID: 18339640
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alzheimer's pathology targets distinct memory networks in the ageing brain.
    Maass A; Berron D; Harrison TM; Adams JN; La Joie R; Baker S; Mellinger T; Bell RK; Swinnerton K; Inglis B; Rabinovici GD; Düzel E; Jagust WJ
    Brain; 2019 Aug; 142(8):2492-2509. PubMed ID: 31199481
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proteasome inhibition by paired helical filament-tau in brains of patients with Alzheimer's disease.
    Keck S; Nitsch R; Grune T; Ullrich O
    J Neurochem; 2003 Apr; 85(1):115-22. PubMed ID: 12641733
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of Cortical β-Amyloid Protein in the Absence of Insoluble Deposits With Alzheimer Disease.
    Yu L; Petyuk VA; Tasaki S; Boyle PA; Gaiteri C; Schneider JA; De Jager PL; Bennett DA
    JAMA Neurol; 2019 Jul; 76(7):818-826. PubMed ID: 31009033
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cerebral cortical Aβ42 and PHF-τ in 325 consecutive brain autopsies stratified by diagnosis, location, and APOE.
    Postupna N; Keene CD; Crane PK; Gonzalez-Cuyar LF; Sonnen JA; Hewitt J; Rice S; Howard K; Montine KS; Larson EB; Montine TJ
    J Neuropathol Exp Neurol; 2015 Feb; 74(2):100-9. PubMed ID: 25575135
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ELISA-quantitation of phosphorylated tau protein in the Alzheimer's disease brain.
    Herrmann M; Golombowski S; Kräuchi K; Frey P; Mourton-Gilles C; Hulette C; Rosenberg C; Müller-Spahn F; Hock C
    Eur Neurol; 1999; 42(4):205-10. PubMed ID: 10567816
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of multiple tau-PET measures as biomarkers in aging and Alzheimer's disease.
    Maass A; Landau S; Baker SL; Horng A; Lockhart SN; La Joie R; Rabinovici GD; Jagust WJ;
    Neuroimage; 2017 Aug; 157():448-463. PubMed ID: 28587897
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tau pathology-dependent remodelling of cerebral arteries precedes Alzheimer's disease-related microvascular cerebral amyloid angiopathy.
    Merlini M; Wanner D; Nitsch RM
    Acta Neuropathol; 2016 May; 131(5):737-52. PubMed ID: 26988843
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New immunoassay for the mapping of neurofibrillary degeneration in Alzheimer's disease using two monoclonal antibodies against human paired helical filament tau proteins.
    Condamines O; Buée-Scherrer V; Boissier L; Wattez A; Delacourte A; Pau B; Mourton-Gilles C
    Neurosci Lett; 1995 Jun; 192(2):81-4. PubMed ID: 7675326
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.